Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -20.894% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) COc1ccc(-n2c(=S)[nH]c3cc(C(=O)Nc4ccccc4OC)ccc3c2=O)c(OC)c1
b.) COc1cc(C(=O)N2CCN(C(=O)c3cc(-c4ccccc4)n[nH]3)CC2)cc(OC)c1OC
c.) CN(CC(=O)Nc1ccc(F)cc1)C(=O)C1CCN(S(=O)(=O)c2ccc3c(c2)OCCO3)CC1
Answer: c. CN(CC(=O)Nc1ccc(F)cc1)C(=O)C1CCN(S(=O)(=O)c2ccc3c(c2)OCCO3)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN(CC(=O)Nc1ccc(F)cc1)C(=O)C1CCN(S(=O)(=O)c2ccc3c(c2)OCCO3)CC1
CN(CC(=O)Nc1ccc(F)cc1)C(=O)C1CCN(S(=O)(=O)c2ccc3c(c2)OCCO3)CC1
1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-N-[2-(4-fluoroanilino)-2-oxoethyl]-N-methylpiperidine-4-carboxamide